Evaluating self- vs interviewer-administered screening for depression in sickle cell disease
Blood Adv
.
2024 Feb 13;8(3):699-702.
doi: 10.1182/bloodadvances.2023012083.
Authors
Maria Lysandrou
1
,
Nives Quaye
2
,
Kristina Landes
2
,
Regina D Crawford
2
,
Payal Desai
3
,
Susan Creary
4
,
Patrick M Schnell
5
,
Robert M Cronin
2
Affiliations
1
The Ohio State University College of Medicine, Columbus, OH.
2
Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH.
3
Hematology, Levine Cancer Institute, Atrium Health, Charlotte, NC.
4
Center for Child Health Equity Outcomes and Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH.
5
Division of Biostatistics, The Ohio State University College of Public Health, Columbus, OH.
PMID:
38113469
PMCID:
PMC10844810
DOI:
10.1182/bloodadvances.2023012083
No abstract available
MeSH terms
Anemia, Sickle Cell* / complications
Anemia, Sickle Cell* / diagnosis
Depression* / diagnosis
Depression* / etiology
Humans
Surveys and Questionnaires